MAJIC: A Phase III Prospective, Multicenter, Randomized, OpenLabel Trial of Acalabrutinib plus Venetoclax versus Venetoclax plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Project: Research

Project Details

StatusActive
Effective start/end date22/11/2221/11/27